Feedback

Pfizer, Biontech apply for registration of their Covid-19 vaccine

Source : 112 Ukraine

The relevant documents were submitted to the U.S. Food and Drug Administration
19:15, 20 November 2020

American biotech company Pfizer
Sky News

American biotech company Pfizer and German Biontech have applied for registration of their coronavirus vaccine in the United States. This was reported by the press service of the concern.

The documents are submitted to the U.S. Food and Drug Administration (FDA). The concern has also sent applications for registration of the vaccine to other countries, including Australia, Great Britain, Europe, Canada, and Japan.

Related: Moderna announces approximate cost of its Covid-19 vaccine

According to current forecasts, companies plan to produce up to 50 million doses of the vaccine in 2020 and up to 1.3 billion doses by the end of 2021. However, Biontech and Pfizer said that they were ready to distribute the vaccine within a few hours after the vaccine was registered.

As we reported earlier, Ukraine's Health Minister Maksym Stepanov stated that there were enough facilities to provide a cold chain for storage of the coronavirus vaccine.

"Ukraine is ready. We also have refrigeration units that can store the vaccine at -70 degrees celsius," the minister commented.

Related: Ukraine expects U.S. to assist in signing contracts with Covid-19 vaccine suppliers

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more